PMCF to Assess Real-life Usage Effectiveness, Safety and Patient Satisfaction of a Range of Hypertonic Seawater-based Decongestant Nasal Sprays

CompletedOBSERVATIONAL
Enrollment

534

Participants

Timeline

Start Date

November 4, 2023

Primary Completion Date

February 13, 2025

Study Completion Date

February 25, 2025

Conditions
Allergic RhinitisURTI
Interventions
DEVICE

ProRhinel Naturel spray nasal/ Allergic rhinitis

ProRhinel Naturel spray nasal: 21 days; 1 spray per nostril; 3 to 6 times per day

DEVICE

ProRhinel EXTRA Eucalyptus spray nasal

ProRhinel EXTRA Eucalyptus spray nasal: until resolution of symptoms (period of 14 days maximum) ; 2 to 3 sprays per nostril; 6 times per day maximum

DEVICE

RESPIMER Enfant

RESPIMER Enfant: until resolution of symptoms (period of 14 days maximum) ; 1 spray per nostril; 4 times per day maximum

DEVICE

Phytosun Aroms spray nasal MAX

Phytosun Aroms spray nasal MAX: until resolution of symptoms (period of 14 days maximum) ; 1 spray per nostril; up to 4-6 times per day

DEVICE

PHYSIOMER RHUME TRIPLE ACTION

PHYSIOMER RHUME TRIPLE ACTION: until resolution of symptoms (period of 14 days maximum) ; 1 spray per nostril; up to 4-6 times per day

DEVICE

Phytosun Aroms spray nasal decongestionnant

Phytosun Aroms spray nasal decongestionnant : until resolution of symptoms (period of 14 days maximum) ; 1 spray per nostril; 6 times per day maximum

DEVICE

ProRhinel Naturel spray nasal/ URTI

ProRhinel Naturel spray nasal: until resolution of symptoms (period of 14 days maximum) ; 1 spray per nostril; 3 to 6 times per day

Trial Locations (2)

Unknown

Alexandra Crevecoeur, Honfleur

Annie Le Gall, Vern-sur-Seiche

Sponsors
All Listed Sponsors
collaborator

Slb Pharma

OTHER

lead

Laboratoire de la Mer

INDUSTRY